Efficacy and Safety of Ramelteon on Chronic Insomnia

Status:
Completed

Trial end date:
2003-12-01

Target enrollment:

Participant gender:

The purpose of this study is to determine the dose response of Ramelteon, once daily (QD), in Japanese subjects with Chronic Insomnia

Phase 2

Takeda